Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function.
Hu
F
F
Wang
X
X
Pace
T W W
TW
Wu
H
H
Miller
A H
AH
D000818:Animals; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006727:Hormone Antagonists / Q000494:pharmacology; D015735:Mifepristone / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects* / Q000201:enzymology; D016716:PC12 Cells; D011720:Pyrazoles / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D011965:Receptors, Glucocorticoid / Q000187:drug effects* / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology* / Q000627:therapeutic use
D016861:Cyclooxygenase Inhibitors; D006727:Hormone Antagonists; D011720:Pyrazoles; D011965:Receptors, Glucocorticoid; D013449:Sulfonamides; D015735:Mifepristone; D000068579:Celecoxib